Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood

• Publication date

  2003-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2002-08-2663PMID 12424191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant Rat Stem Cell Factor Synergizes With Recombinant Human Granulocyte Colony-Stimulating Factor In Vivo in Mice to Mobilize Peripheral Blood Progenitor Cells That Have Enhanced Repopulating Potential

  2003cited by this paper
• Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.

  2002cited by this paper
• Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.

  2002cited by this paper
• Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

  2002cited by this paper
• Retroviral transduction and engraftment ability of primate hematopoietic progenitor and stem cells transduced under serum-free versus serum-containing conditions.

  2002cited by this paper
• Assessment of rapid remobilization intervals with G–CSF and SCF in murine and rhesus macaque models

  2001cited by this paper
• Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver.

  2001cited by this paper
• Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates.

  2001cited by this paper
• Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

  2000cited by this paper
• Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.

  2000cited by this paper
• Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods.

  2000cited by this paper
• SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways.

  2000cited by this paper
• Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells

  2000cited by this paper
• Engraftment of Hematopoietic Progenitor Cells Transduced with the Fanconi Anemia Group C Gene (FANCC)

  1999cited by this paper
• Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial.

  1999cited by this paper
• A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.

  1999cited by this paper
• Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning.

  1999cited by this paper
• T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates

  1998cited by this paper
• The Fluctuating Phenotype of the Lymphohematopoietic Stem Cell with Cell Cycle Transit

  1998cited by this paper
• Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.

  1998cited by this paper
• Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.

  1998cited by this paper
• Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.

  1998cited by this paper
• c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities.

  1998cited by this paper
• Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors.

  1998cited by this paper
• Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor.

  1998cited by this paper
• FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction.

  1997cited by this paper
• Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.

  1997cited by this paper
• Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts.

  1997cited by this paper
• In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor.

  1997cited by this paper
• Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trial.

  1997cited by this paper
• Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.

  1997cited by this paper
• Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.

  1997cited by this paper
• Gene Transfer into Hematopoietic Stem Cells of Nonhuman Primates

  1996cited by this paper
• Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.

  1996cited by this paper
• The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction.

  1996cited by this paper
• Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor.

  1996cited by this paper
• Bone marrow gene transfer in three patients with adenosine deaminase deficiency.

  1996cited by this paper
• Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.

  1996cited by this paper
• Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential.

  1996cited by this paper
• Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates.

  1995cited by this paper
• Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

  1995cited by this paper
• Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation.

  1995cited by this paper
• Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts.

  1995cited by this paper
• Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice.

  1995cited by this paper
• Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates

  1995cited by this paper
• Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor.

  1994cited by this paper
• Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs.

  1994cited by this paper
• In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.

  1994cited by this paper
• Mobilization of long-term hematopoietic reconstituting cells in mice by the combination of stem cell factor plus granulocyte colony-stimulating factor.

  1994cited by this paper
• Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

  1993cited by this paper
• Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells.

  1993cited by this paper
• Evidence that retroviruses integrate into post‐replication host DNA.

  1993cited by this paper
• Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential.

  1993cited by this paper
• Integration of murine leukemia virus DNA depends on mitosis.

  1993cited by this paper
• Treatment of Patients with Severe Combined Immunodeficiency due to Adenosine Deaminase (ADA) Deficiency by Autologous Transplantation of Genetically Modified Bone Marrow Cells. University Hospital Leiden and Institute of Applied Radiobiology and Immunology TNO, The Netherlands

  1992cited by this paper
• The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons.

  1992cited by this paper
• Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells.

  1992cited by this paper
• Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

  1990cited by this paper
• Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

  1986cited by this paper

• Clonal tracking of haematopoietic cells: insights and clinical implications

  2020cites this paper
• Collection of hematopoietic CD34 stem cells in rhesus macaques using Spectra Optia

  2017cites this paper
• primates The impact of low-dose busulfan on clonal dynamics in nonhuman

  2013cites this paper
• Glioma as an Ecosystem : Studies of Invasion, Onco-miR Addiction and Mast Cell Infiltration

  2012cites this paper
• Mobilization for Gene Therapy

  2012cites this paper
• The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution

  2010cites this paper
• Tissue Engineering Strategies for the Treatment of Peripheral Vascular Diseases

  2010cites this paper
• STRATEGIES FOR THE TREATMENT OF FANCONI ANEMIA

  2010cites this paper
• Gene therapy for β-thalassaemia: the continuing challenge

  2010cites this paper
• Use of murine models to test novel gene transfer strategies for the treatment of fanconi anemia

  2010cites this paper
• Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials.

  2009cites this paper
• Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model.

  2009cites this paper
• Desarrollo de vectores lentivirales para terapia génica del síndrome de Hiper-IgM ligado al cromosoma X (X-HIGM1)

  2009cites this paper
• Desarrollo de vectores lentivirales para terapia génica del síndrome de Hiper-IgM ligado al cromosoma X (X-HIGM1)

  2009cites this paper
• Genetic Manipulation of Hematopoietic Stem Cells

  2009cites this paper
• Additive effect of endothelial progenitor cell mobilization and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs.

  2007cites this paper
• The genetic engineering of hematopoietic stem cells: the rise of lentiviral vectors, the conundrum of the ltr, and the promise of lineage-restricted vectors.

  2007cites this paper
• Hematopoietic stem-cell behavior in nonhuman primates.

  2007cites this paper
• AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

  2006cites this paper
• In Vitro Culture During Retroviral Transduction Improves Thymic Repopulation and Output After Total Body Irradiation and Autologous Peripheral Blood Progenitor Cell Transplantation in Rhesus Macaques

  2006cites this paper
• Efficient transduction and engraftment of G-CSF-mobilized peripheral blood CD34+ cells in nonhuman primates using GALV-pseudotyped gammaretroviral vectors.

  2006cites this paper
• In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector.

  2006cites this paper
• Combined Sustained Delivery of Basic Fibroblast Growth Factor and Administration of Granulocyte Colony-Stimulating Factor: Synergistic Effect on Angiogenesis in Mouse Ischemic Limbs

  2006cites this paper
• Adult Stem Cells and Gene Therapy

  2006cites this paper
• Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model.

  2006cites this paper
• Stem Cell Gene Transfer: Insights into Integration and Hematopoiesis from Primate Genetic Marking Studies

  2005cites this paper
• Hematopoietic stem cell gene therapy: dead or alive?

  2005cites this paper
• Hematopoietic Stem Cell Transduction and Amplification in Large Animal Models

  2005cites this paper
• Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

  2005cites this paper
• Hematopoietic stem cell-based gene therapy against HIV infection: promises and caveats.

  2005cites this paper
• Large Animal Models for Stem and Progenitor Cell Analysis

  2005cites this paper
• In vivo gene marking of rhesus macaque long‐term repopulating hematopoietic cells using a VSV‐G pseudotyped versus amphotropic oncoretroviral vector

  2004cites this paper
• Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol.

  2004cites this paper
• Comparison of Retroviral Transduction Efficiency in CD34+ Cells Derived from Bone Marrow versus G‐CSF–Mobilized or G‐CSF Plus Stem Cell Factor–Mobilized Peripheral Blood in Nonhuman Primates

  2004cites this paper
• Biodistribution of the RD114/mammalian type D retrovirus receptor, RDR

  2004cites this paper
• Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system.

  2004cites this paper
• Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells

  2004cites this paper
• The impact of low-dose busulfan on clonal dynamics in nonhuman primates.

  2004cites this paper
• Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice.

  2004cites this paper
• Cytokines: value-added products in hematopoietic stem cell gene therapy.

  2004cites this paper
• Stem cell gene transfer--efficacy and safety in large animal studies.

  2004cites this paper
• Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor

  2004cites this paper
• Stem and progenitor cell therapies: insights from non-human primate models.

  2004cites this paper
• Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia.

  2004cites this paper
• Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates.

  2004cites this paper
• Synergistic Effect of Bone Marrow Mobilization and Vascular Endothelial Growth Factor-2 Gene Therapy in Myocardial Ischemia

  2004cites this paper
• Strategies to expand transduced hematopoietic stem cells in vivo.

  2004cites this paper
• 53 – Hematopoietic Stem Cell Mobilization and Homing

  2004cites this paper
• Competitive Repopulation Assay of Two Gene-Marked Cord Blood Units in NOD/SCID/γcnull Mice

  2004cites this paper
• Direct comparison of RD114-pseudotyped versus amphotropic-pseudotyped retroviral vectors for transduction of rhesus macaque long-term repopulating cells.

  2003cites this paper
• Side effects of retroviral gene transfer into hematopoietic stem cells.

  2003cites this paper
• Direct Comparison of Steady-State Marrow, Primed Marrow, and Mobilized Peripheral Blood for Transduction of Hematopoietic Stem Cells in Dogs

  2003cites this paper
• Acta Universitatis Upsaliensis Uppsala 2012

  year unknowncites this paper